Search Results - "MANFREDI, R. L"

Behavioral Demonstration of a Somatosensory Neuroprosthesis by Berg, J. A., Dammann, J. F., Tenore, F. V., Tabot, G. A., Boback, J. L., Manfredi, L. R., Peterson, M.L., Katyal, K. D., Johannes, M. S., Makhlin, A., Wilcox, R., Franklin, R. K., Vogelstein, R. J., Hatsopoulos, N. G., Bensmaia, S. J.

“…Tactile sensation is critical for effective object manipulation, but current prosthetic upper limbs make no provision for delivering somesthetic feedback to…”
Get full text

Clinical factors contributing to the differential diagnosis of primary insomnia and insomnia related to mental disorders by NOWELL, P. D, BUYSSE, D. J, VGONTZAS, A. N, STAPF, D. M, HOUCK, P. R, KUPFER, D. J, REYNOLDS, C. F, HAURI, P. J, ROTH, T, STEPANSKI, E. J, THORPY, M. J, BIXLER, E, KALES, A, MANFREDI, R. L

“…OBJECTIVE: Primary insomnia and insomnia related to mental disorders are the two most common DSM-IV insomnia diagnoses, but distinguishing between them is…”
Get full text

Next-day memory impairment with triazolam use by Bixler, E O, Kales, A, Manfredi, R L, Vgontzas, A N, Tyson, K L, Kales, J D

“…The prevalence, rate, and degree of memory impairment for next-day activities during a short, intermittent course of bedtime doses of triazolam, temazepam, and…”
Get more information

Diagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial by Buysse, D J, Reynolds, 3rd, C F, Hauri, P J, Roth, T, Stepanski, E J, Thorpy, M J, Bixler, E O, Kales, A, Manfredi, R L, Vgontzas, A N

“…The frequency and ranking of DSM-IV sleep disorder diagnoses of clinical patients with complaints of insomnia, as well as rates of diagnostic agreement and…”
Get more information

Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines by Kales, A, Manfredi, R L, Vgontzas, A N, Bixler, E O, Vela-Bueno, A, Fee, E C

“…In three parallel groups, brief and intermittent administration and withdrawal of triazolam, 0.5 mg, temazepam, 30 mg, and placebo were assessed in a 12-night…”
Get more information

Effects of lovastatin and pravastatin on sleep efficiency and sleep stages by Vgontzas, A N, Kales, A, Bixler, E O, Manfredi, R L, Tyson, K L

“…The effects on sleep of two 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (40 mg lovastatin and 40 mg pravastatin) were evaluated in 12 normal…”
Get more information

Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome by BAKER, E. R, BEST, R. G, MANFREDI, R. L, DEMERS, L. M, WOLF, G. C

“…To further investigate the efficacy of progesterone in the treatment of the symptoms of premenstrual syndrome (PMS). From an initial cohort of 25 subjects…”
Get full text

Validity and clinical utility of sleep laboratory criteria for insomnia by Vgontzas, A N, Bixler, E O, Kales, A, Manfredi, R L, Tyson, K

“…The sensitivity, specificity, and positive predictive value of two proposed sleep laboratory criteria for the diagnosis of insomnia were evaluated in 375…”
Get more information

Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam by Kales, A, Bixler, E O, Vela-Bueno, A, Soldatos, C R, Niklaus, D E, Manfredi, R L

“…Two benzodiazepine hypnotics, triazolam, 0.25 mg, with a short elimination t1/2, and quazepam, 15 mg, with a long t1/2, were evaluated in 22-night sleep…”
Get more information

Triazolam and memory loss by Bixler, E O, Kales, A, Manfredi, R L, Vgontzas, A N

Get more information

Clonazepam: sleep laboratory study of efficacy and withdrawal by Kales, A, Manfredi, R L, Vgontzas, A N, Baldassano, C F, Kostakos, K, Kales, J D

“…Clonazepam 0.5 mg was evaluated in a sleep laboratory study of 6 insomniac patients. The 16-night protocol consisted of 4 placebo-baseline nights, 7 nights of…”
Get more information

Alprazolam: effects on sleep and withdrawal phenomena by Kales, A, Bixler, E O, Vela-Bueno, A, Soldatos, C R, Manfredi, R L

“…Alprazolam was evaluated in chronic insomniacs in a 1-mg bedtime dose. The 16-night sleep laboratory protocol included four placebo-baseline nights followed by…”
Get more information

Uvulopalatopharyngoplasty as a treatment of obstructive sleep apnea precipitated by uvular prolapse by Cadieux, R J, Manders, E K, Manfredi, R L, Bixler, E O, Kales, A

“…Two patients are discussed in whom obstructive sleep apnea was precipitated by uvular prolapse into the larynx and successfully treated by…”
Get more information

An update on sleep disorders by Manfredi, R L, Vgontzas, A, Kales, A

“…Sleep disorders are so common that approximately 38% of the general population complains about a current sleep problem and 52% complains about a current or…”
Get more information

Clinical neuropharmacology of sleep disorders by Manfredi, R L, Kales, A

“…Within the context of the comprehensive treatment of sleep disorders, which includes medical, neurologic, psychiatric, and social interventions, use of…”
Get more information

Effects of nadolol on blood pressure, sleep efficiency, and sleep stages by Kales, A, Bixler, E O, Vela-Bueno, A, Cadieux, R J, Manfredi, R L, Bitzer, S, Kantner, T

“…The effects of nadolol (20 and 80 mg) on blood pressure and sleep parameters were assessed in six patients with mild hypertension. A 32-night experimental…”
Get more information

Disorders of excessive sleepiness: narcolepsy and hypersomnia by Manfredi, R L, Brennan, R W, Cadieux, R J

“…Besides sleep apnea, the main disorders of excessive daytime sleepiness include narcolepsy and hypersomnia. Narcolepsy is characterized by periods of…”
Get more information

Usefulness of polysomnographic studies in the differential diagnosis of insomnia by Vgontzas, A N, Kales, A, Bixler, E O, Manfredi, R L, Vela-Bueno, A

“…The prevalence of sleep apnea, sleep apneic activity, nocturnal myoclonus, and nocturnal myoclonic activity was assessed in 375 outpatient insomniacs and 150…”
Get more information

Buspirone: sedative or stimulant effect? by Manfredi, R L, Kales, A, Vgontzas, A N, Bixler, E O, Isaac, M A, Falcone, C M

“…The primary objectives of this study were to evaluate the effects of initial and continued administration of buspirone on sleep induction and maintenance and…”
Get more information

Inhibition of theophylline metabolism by long-term allopurinol administration by Manfredi, R L, Vesell, E S

“…Administration of an oral dose of allopurinol (300 mg every 12 hr) for 14 consecutive days increased the mean theophylline area under the curve (AUC) 27% and…”
Get more information